Healthcare -
Biotechnology - NASDAQ - US
$ 23.46
-0.509 %
$ 3.38 B
Market Cap
-8.5
P/E
DNLI - GROSS PROFIT
Gross Profit DNLI - Denali Therapeutics Inc.
314 M
LAST VALUE
169.98%
2 YEAR CAGR
20.85%
5 YEAR CAGR
0.00%
10 YEAR CAGR